...
首页> 外文期刊>Iranian red crescent medical journal >Effects of Acetaminophen consumption in asthmatic children
【24h】

Effects of Acetaminophen consumption in asthmatic children

机译:服用对乙酰氨基酚对哮喘儿童的影响

获取原文

摘要

Acetaminophen exposure might be associated with increasing risk of asthma prevalence and other atopic disorders over recent decades. The present study aimed to investigate the association between acetaminophen exposure and the risk of developing childhood asthma. Methods: A case - control study was undertaken between March and September 2010 in Urmia district north west of Iran. Subjects were children aged between 2 - 8 years old. Cases were asthmatic children diagnosed based on GINA criteria (n=207) and controls were children without asthma symptoms (n=414) using 1:2 sampling method. Cases and controls were matched for age and gender. Clinical data including Acetaminophen exposure was collected by a questionnaire which completed by interviewing with parents/ guardians. Results: Using Acetaminophen during the first year of life had no any effect on the risk of asthma (p=0.19), but amongst 2-8 years old children, this association was observed (p<0.001). There was also a dose response association between Acetaminophen consumption and risk of asthma (OR: 3.8; 95% CI; 2.15 6.59 for once per 2 to 3 month and OR: 4.2; 2.50 - 7.3 for at least one per month). Conclusions: Using Acetaminophen increases risk of asthma among 2 - 8 years old children. However stronger evidences are required to design evidence-based guidelines to reduce acetaminophen consumption following post - vaccination and other febrile disorders.
机译:在过去的几十年中,对乙酰氨基酚暴露可能与哮喘患病率和其他特应性疾病风险增加有关。本研究旨在调查对乙酰氨基酚暴露与患儿哮喘的风险之间的关系。方法:2010年3月至2010年9月在伊朗西北部的Urmia区进行了病例对照研究。受试者为2-8岁的儿童。病例为根据GINA标准诊断为哮喘的儿童(n = 207),对照组为无哮喘症状的儿童(n = 414),采用1:2抽样方法。根据年龄和性别匹配病例和对照。通过问卷调查收集包括对乙酰氨基酚暴露在内的临床数据,该问卷通过与父母/监护人进行访谈来完成。结果:在出生后第一年使用对乙酰氨基酚对哮喘风险没有任何影响(p = 0.19),但在2-8岁的儿童中观察到这种关联(p <0.001)。对乙酰氨基酚的摄入量与哮喘风险之间也存在剂量反应相关性(OR:3.8; 95%CI;每2至3个月一次,2.15 6.59; OR:4.2; 2.50-7.3,至少每月1次)。结论:使用对乙酰氨基酚会增加2-8岁儿童的哮喘风险。但是,需要更强有力的证据来设计基于证据的指南,以减少接种疫苗和其他发热性疾病后对乙酰氨基酚的消费。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号